Efficacy and tolerability of rizatriptan 10 mg compared with sumatriptan 100 mg: An evidence-based analysis

Expert Review of Neurotherapeutics

Volumn 10, Issue 4, 2010, Pages 499-506

  Göbel, Hartmut ^a  

^a Kiel Headache Center   (Germany)

Author keywords

acute attack; consistency; migraine; oral treatment; pain relief; pain free; rizatriptan; sumatriptan; tolerability

Indexed keywords

ALMOTRIPTAN; ELETRIPTAN; NARATRIPTAN; PLACEBO; RIZATRIPTAN; SUMATRIPTAN; ZOLMITRIPTAN; SEROTONIN AGONIST; TRIAZOLE DERIVATIVE; TRYPTAMINE DERIVATIVE;

ACUTE DISEASE; CLINICAL TRIAL (TOPIC); DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; META ANALYSIS (TOPIC); MIGRAINE; MULTICENTER STUDY (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT RESPONSE; DOUBLE BLIND PROCEDURE; EVIDENCE BASED MEDICINE; META ANALYSIS; PATIENT ATTITUDE; RANDOMIZED CONTROLLED TRIAL;

DOUBLE-BLIND METHOD; EVIDENCE-BASED MEDICINE; HUMANS; META-ANALYSIS AS TOPIC; MIGRAINE DISORDERS; PATIENT PREFERENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN AGONISTS; SUMATRIPTAN; TRIAZOLES; TRYPTAMINES;

EID: 77953644272     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.10.24     Document Type: Review

References (17)

1. Diener HC, Putzki N, Berlit P et al. Leitlinien für Diagnostik und Therapie in der Neurologie. Georg Thieme Verlag, Stuttgart, Germany (2005).
2. Lee Y, Conroy JA, Stepanavage ME et al. Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers. Br. J. Clin. Pharmacol. 47(4), 373-378 (1999).
3. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N. Engl. J. Med. 346, 257-270 (2002).
4. Tfelt-Hansen P, Teall J, Rodriguez F et al. Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group. Headache 38(10), 748-755 (1998).
5. Goldstein J, Ryan R, Jiang K et al. Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group. Headache 38(10), 737-747 (1998).
6. Kolodny A, Polis A, Battisti W P, Johnson-Pratt L, Skobieranda F.; Rizatriptan Protocol 052 Study Group. Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets. Cephalalgia 24, 540-546 (2004).
7. Pascual J, Vega P, Diener HC, Allen C, Vrijens F, Patel K. Comparison of rizatriptan 10 mg vs zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group. Cephalalgia 20(5), 455-461 (2000).
8. Bomhof M, Paz J, Legg N, Allen C, Vandormael K, Patel K. Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine. Eur. Neurol. 42(3), 173-179 (1999).
9. Ng-Mak DS, Hu XH, Chen Y, Ma L, Solomon G. Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans. J. Clin. Pract. 61, 1091-1111 (2007).
10. Pascual J, Bussone G, Hernandez JF et al. Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg on migraine. Eur. Neurol. 45, 275-283 (2001).
11. Ferrari MD, Roon KI, Lipton RB, Goadsky PJ. Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358, 1668-1675 (2001).
12. Kramer MS, Matzura-Wolfe D, Polis A et al. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group. Neurology 51(3), 773-781 (1998).
13. Belsey JD. Reconciling effectiveness and tolerability in oral triptan therapy: a quantitative approach to decision making in migraine management. J. Clin. Res. 4, 105-125 (2003).
14. Bussone G, D'Amico D, McCarroll KA, Gerth W, Lines CR. Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials. Eur. Neurol. 48, 172-177 (2002).
15. Belsey JD. Cost effectiveness of oral triptan therapy: a trans-national comparison based on a meta-analysis of randomised controlled trials. Curr. Med. Res. Opin. 20, 659-669 (2004).
16. Pascual J, Fité B, López-Gil A. Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain. Headache 42, 93-98 (2002).
17. Haag G. Migraine and quality of life - results of the MELT survey. Nervenheilkunde 23, 297-300 (2004).